UPDATE: IDEXX Labs (IDXX) Tops Q4 EPS by 62c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to UPDATE: IDEXX Labs (IDXX) Tops Q4 EPS by 62c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus

IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results

February 2, 2021 6:30 AM EST

WESTBROOK, Maine, Feb. 2, 2021 /PRNewswire/ -- 

Achieves fourth quarter reported revenue growth of 19% and organic growth of 17%, driven by CAG Diagnostics recurring revenue reported growth of 23% and organic growth of 21% High revenue growth supported by sustained strong global trends in pet healthcare Delivers full year EPS of $6.71, an increase of 37% on a reported basis and 31% on a comparable constant currency basis Strong full year EPS results supported by operating margin expansion of 270 basis points on a reported basis and 340 basis points on a comparable constant currency basis... More